Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism

被引:3
|
作者
Wang, Yi-Jun [1 ]
Xie, Xiao-Li [1 ]
Liu, Hong-Qun [2 ]
Tian, Hui [1 ]
Jiang, Xiao-Yu [1 ]
Zhang, Jiu-Na
Chen, Sheng-Xiong [3 ]
Liu, Ting [4 ]
Wang, Shu-Ling [4 ]
Zhou, Xue [1 ]
Jin, Xiao-Xu [1 ]
Liu, Shi-Mao [5 ]
Jiang, Hui-Qing [1 ]
机构
[1] Hebei Med Univ, Hosp 2, Dept Gastroenterol, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China
[2] Univ Calgary, Liver Unit, Calgary, AB T1W 0K6, Canada
[3] Hebei Med Univ, Hosp 2, Dept Hepatobiliary Surg, Shijiazhuang 050000, Hebei, Peoples R China
[4] Hebei Med Univ, Hosp 1, Dept Gastroenterol, Shijiazhuang 050000, Hebei, Peoples R China
[5] Hebei Youfu Hosp, Dept Gastroenterol, Shijiazhuang 050000, Hebei, Peoples R China
关键词
Prostaglandin F(2 alpha)synthase; Colorectal cancer; Oxaliplatin; Drug resistance; DNA damage; RECTAL-CANCER; DRUG-RESISTANCE; CISPLATIN; AKR1C3; EXPRESSION; OVEREXPRESSION; INHIBITION; RECEPTOR; REPAIR; CELLS;
D O I
10.3748/wjg.v29.i39.5452
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDOxaliplatin (Oxa) is the first-line chemotherapy drug for colorectal cancer (CRC), and Oxa resistance is crucial for treatment failure. Prostaglandin F-2 alpha synthase (PGF(2 alpha)) (PGFS), an enzyme that catalyzes the production of PGF(2 alpha), is involved in the proliferation and growth of a variety of tumors. However, the role of PGFS in Oxa resistance in CRC remains unclear. AIMTo explore the role and related mechanisms of PGFS in mediating Oxa resistance in CRC. METHODSThe PGFS expression level was examined in 37 pairs of CRC tissues and paracancerous tissues at both the mRNA and protein levels. Overexpression or knockdown of PGFS was performed in CRC cell lines with acquired Oxa resistance (HCT116-OxR and HCT8-OxR) and their parental cell lines (HCT116 and HCT8) to assess its influence on cell proliferation, chemoresistance, apoptosis, and DNA damage. For determination of the underlying mechanisms, CRC cells were examined for platinum-DNA adducts and reactive oxygen species (ROS) levels in the presence of a PGFS inhibitor or its products. RESULTSBoth the protein and mRNA levels of PGFS were increased in the 37 examined CRC tissues compared to the adjacent normal tissues. Oxa induced PGFS expression in the parental HCT116 and HCT8 cells in a dose-dependent manner. Furthermore, overexpression of PGFS in parental CRC cells significantly attenuated Oxa-induced proliferative suppression, apoptosis, and DNA damage. In contrast, knockdown of PGFS in Oxa-resistant HCT116 and HCT8 cells (HCT116-OxR and HCT8-OxR) accentuated the effect of Oxa treatment in vitro and in vivo. The addition of the PGFS inhibitor indomethacin enhanced the cytotoxicity caused by Oxa. Treatment with the PGFS-catalyzed product PGF(2 alpha) reversed the effect of PGFS knockdown on Oxa sensitivity. Interestingly, PGFS inhibited the formation of platinum-DNA adducts in a PGF(2 alpha)-independent manner. PGF(2 alpha) exerts its protective effect against DNA damage by reducing ROS levels. CONCLUSION PGFS promotes resistance to Oxa in CRC via both PGF(2 alpha)-dependent and PGF(2 alpha)-independent mechanisms.
引用
收藏
页码:5452 / 5470
页数:19
相关论文
共 50 条
  • [41] Prostaglandin F2 alpha analogues in glaucoma management
    Teus, Miguel A.
    Arranz-Marquez, Esther
    EXPERT REVIEW OF OPHTHALMOLOGY, 2008, 3 (02) : 203 - 209
  • [42] Pregnancy termination in canine mismating with Prostaglandin F2α
    Balasubramanian, S
    Sridevi, P
    Prathaban, S
    Pattabiraman, SR
    INDIAN VETERINARY JOURNAL, 2003, 80 (07): : 689 - 690
  • [43] Role of prostaglandin F2α in cell luteinization.
    Meidan, R
    Mamluk, R
    Girsh, E
    BIOLOGY OF REPRODUCTION, 1998, 58 : 80 - 80
  • [44] Prostaglandin F2α receptors in the human trabecular meshwork
    Anthony, TL
    Pierce, KL
    Stamer, WD
    Regan, JW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1998, 39 (02) : 315 - 321
  • [45] On sofic approximations of F2 x F2
    Ioana, Adrian
    ERGODIC THEORY AND DYNAMICAL SYSTEMS, 2022, 42 (07) : 2333 - 2351
  • [46] The origin of prostaglandin F2α in human urine.
    Yin, H
    Porter, N
    Morrow, JD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P38 - P38
  • [47] Effect of prostaglandin F2α on seasonality of swine reproduction
    Peña, FJ
    Domínguez, JC
    Alegre, B
    VETERINARY RECORD, 1998, 142 (08) : 194 - 195
  • [48] Metabolism of 8-iso-prostaglandin F2α
    Basu, S
    FEBS LETTERS, 1998, 428 (1-2) : 32 - 36
  • [49] Promoting effect of prostaglandin F2α on platelet aggregation
    Kashiwagi, Hitoshi
    Yuhki, Koh-ichi
    Imamichi, Yoshitaka
    Kojima, Fumiaki
    Kumei, Shima
    Narumiya, Shuh
    Ushikubi, Fumitaka
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S172 - S172
  • [50] A General Catalyst Controlled Route to Prostaglandin F2α
    Cunningham, Laura
    Mishra, Sourabh
    Matthews, Leon
    Fletcher, Stephen P.
    ORGANIC LETTERS, 2022, 24 (48) : 8886 - 8889